Drugs / Tick-Borne Encephalitis vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00311493 | Feb 2006 → ? | tick-borne encephalitis | Novartis | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00644059 Comparator | Nov 2007 → Apr 2010 | influenza | Novartis | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tick-Borne Encephalitis vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00311493 ↗ |
| Modality | Vaccine | “Tick-Borne Encephalitis vaccine” NCT00311493 ↗ |
| Route | Intramuscular | “Tick-borne encephalitis vaccine: two IM injections” NCT00644059 ↗ |